Woodward Company Profile

✉ Email this page to a colleague

WOODWARD has fourteen approved drugs.

There is one US patent protecting WOODWARD drugs.

There are twenty-four patent family members on WOODWARD drugs in fourteen countries and fourteen supplementary protection certificates in five countries.

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Woodward	FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	fluconazole	INJECTABLE;INJECTION	077909-002	May 26, 2010	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Woodward	AVANDIA	rosiglitazone maleate	TABLET;ORAL	021071-004	May 25, 1999		DISCN	Yes	No		⤷ Try a Trial				⤷ Try a Trial
Woodward	LOVAZA	omega-3-acid ethyl esters	CAPSULE;ORAL	021654-001	Nov 10, 2004	AB	RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Woodward	LUNESTA	eszopiclone	TABLET;ORAL	021476-001	Dec 15, 2004	7,381,724*PED	⤷ Try a Trial
Woodward	AVANDIA	rosiglitazone maleate	TABLET;ORAL	021071-004	May 25, 1999	5,002,953*PED	⤷ Try a Trial
Woodward	COREG	carvedilol	TABLET;ORAL	020297-003	Sep 14, 1995	4,503,067*PED	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Capsules	0.5 mg	➤ Subscribe	2007-10-29
➤ Subscribe	Capsules	1 g	➤ Subscribe	2008-11-10
➤ Subscribe	Extended-release Capsules	10 mg and 20 mg	➤ Subscribe	2008-03-18
➤ Subscribe	Extended-release Capsules	80 mg	➤ Subscribe	2007-11-19
➤ Subscribe	Capsule	0.5 mg/0.4 mg	➤ Subscribe	2010-10-26
➤ Subscribe	Tablets	1 mg, 2 mg and 3 mg	➤ Subscribe	2008-12-15
➤ Subscribe	Extended-release Capsules	40 mg	➤ Subscribe	2007-12-21

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0306228	C300034	Netherlands	⤷ Try a Trial	PRODUCT NAME: ROSIGLITAZONE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT EN/OF EEN FARMACEUTISCH AANVAARDBAAR SOLVAAT, IN HET BIJZONDER ROSIGLITAZONE MALEAAT; REGISTRATION NO/DATE: EU/1/00/137/001 - EU/1/00/137/012 20000711
0658161	39/2000	Austria	⤷ Try a Trial	PRODUCT NAME: ROSIGLITAZONE MALEAT; NAT. REGISTRATION NO/DATE: EU/1/00/137/001 - EU/1/00/137/012 20000711; FIRST REGISTRATION: LI 55176 19990929
0719278	23/2003	Austria	⤷ Try a Trial	PRODUCT NAME: DUTASTERIDE, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SOLVATES; NAT. REGISTRATION NO/DATE: 1-24844, 1-24845 20030217; FIRST REGISTRATION: SE 17871, 17872 20020719
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.